share_log

MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes

MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes

MindMed:2022年第二季度财务和业务业绩、管理和渠道变化
Benzinga Real-time News ·  2022/08/12 17:34
MindMed (NASDAQ:MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offering a solution, reported its earnings for the quarter ended June 30, 2022. And the next day, it announced the appointment of two independent directors to its board.
MindMed(纳斯达克:MNMD),该公司最近收到了一封代表其一名股东的信,呼吁制定新的业务战略并提供解决方案,该公司报告了截至2022年6月30日的季度收益。第二天,它宣布了委任两名独立董事到它的董事会。
First, a quick financial report: 
首先,一个快速财务报告:
Total cash balance of $105.7 million, expected to be sufficient for the operating requirements beyond key development milestones until 2024. Net cash used in operating activities was $28.0 million within six months, compared to $21.2 million for the same period in 2021.  R&D expenses were $9.3 million within three months, compared...
现金余额合计1.057亿美元,预计将足以满足2024年之前关键发展里程碑以外的业务需求。 ...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发